EXICURE, INC. Amortization of Debt Issuance Costs
EXICURE, INC. (XCUR) reported Amortization of Debt Issuance Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-06-06
- EXICURE, INC. amortization of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- EXICURE, INC. amortization of debt issuance costs for the quarter ending 2023-09-30 was $0.00.
- EXICURE, INC. amortization of debt issuance costs for the quarter ending 2023-06-30 was $0.00.
- EXICURE, INC. amortization of debt issuance costs for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. amortization of debt issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- EXICURE, INC. amortization of debt issuance costs for fiscal 2022 was $477.00K, a 67.96% increase from fiscal 2021.
- EXICURE, INC. amortization of debt issuance costs for fiscal 2021 was $284.00K, a 155.86% increase from fiscal 2020.
- EXICURE, INC. amortization of debt issuance costs for fiscal 2020 was $111.00K, a 42.19% decline from fiscal 2019.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 10-Q · filed 2024-05-16 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $477.00K 10-K · filed 2024-06-06 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $477.00K 10-Q · filed 2024-05-16 | $548.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $477.00K 10-Q/A · filed 2024-06-06 | $548.00K derived: sum of 3 quarters · filed 2024-06-06 | $620.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | $477.00K 10-Q/A · filed 2024-06-06 | $548.00K derived: sum of 2 quarters · filed 2024-06-06 | $620.00K derived: sum of 3 quarters · filed 2024-06-06 | $691.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $143.00K derived: sum of 2 quarters · filed 2023-03-27 | $214.00K derived: sum of 3 quarters · filed 2023-03-27 | $284.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $143.00K derived: sum of 2 quarters · filed 2022-11-14 | $213.00K 10-Q · filed 2022-11-14 | $285.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $141.00K 10-Q · filed 2022-08-15 | $213.00K derived: sum of 3 quarters · filed 2022-08-15 | $217.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $70.00K 10-Q · filed 2022-05-16 | $142.00K derived: sum of 2 quarters · filed 2022-05-16 | $146.00K derived: sum of 3 quarters · filed 2022-05-16 | $146.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $76.00K derived: sum of 2 quarters · filed 2022-03-25 | $76.00K derived: sum of 3 quarters · filed 2022-03-25 | $111.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $4.00K derived: sum of 2 quarters · filed 2021-11-19 | $39.00K 10-Q · filed 2021-11-19 | $92.00K derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $35.00K 10-Q · filed 2021-08-12 | $88.00K derived: sum of 3 quarters · filed 2021-08-12 | $141.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $35.00K 10-Q · filed 2021-05-12 | $88.00K derived: sum of 2 quarters · filed 2021-05-12 | $141.00K derived: sum of 3 quarters · filed 2021-05-12 | $193.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $106.00K derived: sum of 2 quarters · filed 2021-03-11 | $158.00K derived: sum of 3 quarters · filed 2021-03-11 | $192.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $105.00K derived: sum of 2 quarters · filed 2020-11-12 | $139.00K 10-Q · filed 2020-11-12 | $164.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $86.00K 10-Q · filed 2020-08-12 | $111.00K derived: sum of 3 quarters · filed 2020-08-12 | $135.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $34.00K 10-Q · filed 2020-05-14 | $59.00K derived: sum of 2 quarters · filed 2020-05-14 | $83.00K derived: sum of 3 quarters · filed 2020-05-14 | $106.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $49.00K derived: sum of 2 quarters · filed 2020-03-10 | $72.00K derived: sum of 3 quarters · filed 2020-03-10 | $96.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $47.00K derived: sum of 2 quarters · filed 2019-11-07 | $71.00K 10-Q · filed 2019-11-07 | $110.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $47.00K 10-Q · filed 2019-08-08 | $86.00K derived: sum of 3 quarters · filed 2019-09-23 | $135.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $24.00K 10-Q · filed 2019-05-08 | $63.00K derived: sum of 2 quarters · filed 2019-09-23 | $112.00K derived: sum of 3 quarters · filed 2019-09-23 | $163.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2017-12-31 | $39.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $88.00K derived: sum of 2 quarters · filed 2019-09-23 | $139.00K derived: sum of 3 quarters · filed 2019-09-23 | $189.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $100.00K derived: sum of 2 quarters · filed 2018-11-06 | $150.00K 10-Q · filed 2018-11-06 | $206.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $101.00K 10-Q · filed 2018-08-06 | $157.00K derived: sum of 3 quarters · filed 2018-08-06 | |
| 2017-03-31 | $50.00K 10-Q · filed 2018-05-15 | $106.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $193.00K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | $137.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |